Mark James Litton

Insider Reports History

Location
Bothell, WA
Signature
/s/ Mark Worthington, Attorney-in-Fact on behalf of Mark James Litton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark James Litton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. President and CEO, Director Common Stock 40,828 $280,896 $6.88 02 Jan 2026 Direct
Athira Pharma, Inc. President and CEO, Director Restricted Stock Units 0 $125,047 $0.5619 31 Dec 2025 Direct
Athira Pharma, Inc. President and CEO, Director Common Stock 656 $2,833 $4.32 31 Dec 2025 By Irrevocable Trust of OSL
Athira Pharma, Inc. President and CEO, Director Common Stock 656 $2,833 $4.32 31 Dec 2025 By Irrevocable Trust of SWL
Athira Pharma, Inc. President and CEO, Director Common Stock 656 $2,833 $4.32 31 Dec 2025 By Irrevocable Trust of WGL
Athira Pharma, Inc. President and CEO, Director Stock Option (Right to Buy) 133,526 24 Dec 2025 Direct

Insider Reports Filed by Mark James Litton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATHA Athira Pharma, Inc. 31 Dec 2025 3 -$17,792 4 President and CEO, Director 05 Jan 2026, 19:51
ATHA Athira Pharma, Inc. 24 Dec 2025 1 $0 4 President and CEO, Director 29 Dec 2025, 16:17
ATHA Athira Pharma, Inc. 30 Jun 2025 3 -$7,374 4 President and CEO, Director 02 Jul 2025, 16:34
ATHA Athira Pharma, Inc. 03 Mar 2025 2 $0 4 President and CEO, Director 04 Mar 2025, 16:29
ATHA Athira Pharma, Inc. 31 Dec 2024 3 -$14,108 4 President and CEO, Director 03 Jan 2025, 17:04
ATHA Athira Pharma, Inc. 03 Oct 2024 1 $0 4/A President and CEO, Director 03 Oct 2024, 21:50
ATHA Athira Pharma, Inc. 03 Sep 2024 2 -$2,848 4 President and CEO, Director 05 Sep 2024, 19:47
ATHA Athira Pharma, Inc. 15 Feb 2024 1 $0 4 CEO, Director 16 Feb 2024, 17:05
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$14,026 4/A CEO, Director 16 Feb 2024, 16:38
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$14,026 4 Chief Executive Officer, Director 08 Jan 2024, 16:40
ATHA Athira Pharma, Inc. 27 Jan 2023 2 +$1,814 4 Chief Executive Officer, Director 31 Jan 2023, 18:33
ATHA Athira Pharma, Inc. 22 Jun 2022 3 -$16,068 4 Chief Executive Officer, Director 24 Jun 2022, 19:51
ATHA Athira Pharma, Inc. 27 Jan 2022 2 +$11,071 4 Chief Executive Officer, Director 31 Jan 2022, 16:06
ATHA Athira Pharma, Inc. 17 Aug 2021 3 +$80,622 4 Chief Operating Officer 19 Aug 2021, 17:05